US Oncology Financial Analyst Salaries in Wilmington, DE | Comparably
US Oncology operates a network of integrated community-based oncology practices that provides cancer care services in the United States. read more
EMPLOYEE
PARTICIPANTS
80
TOTAL
RATINGS
550

US Oncology Financial Analyst Salaries in Wilmington, DE

The average US Oncology Financial Analyst in Wilmington, DE earns an estimated $69,904 annually, which includes an estimated base salary of $65,304 with a $4,600 bonus. US Oncology's Financial Analyst compensation is $17,496 less than the US average for a Financial Analyst. Financial Analyst salaries at US Oncology in Wilmington, DE can range from $66,000 - $75,000.

In Wilmington, DE, The Finance Department at US Oncology earns $16,645 more on average than the Admin Department.

Last updated 7 months ago.

$22k
$41k
$62k
$82k
$180k
$310k
$375k
$69,904
Average Compensation
$65,304
avg. base
$4,600
avg. bonus

Financial Analyst Salaries at US Oncology

In Wilmington, DE, Financial Analysts earn $1,488 more than Financial Analysts, and $831 less than Accountants.

Accounting Manager
$121k*
Business Analyst
$96k*
Senior Accountant
$92k*
Accountant
$71k*
Financial Analyst
$68k*
* estimated salary

Compensation at US Oncology by Department

In Wilmington, DE, The Finance Department averages $16,645 more than the Admin Department, and $10,806 less than the IT Department

IT
$95,561 Avg. total comp.
+$11k
Finance
$84,755 Avg. total comp.
Admin
$68,110 Avg. total comp.
-$17k

Financial Analyst Compensation by Gender (All Companies)

The average female Financial Analyst at companies similar size to US Oncology reported making $93,556, while the average male Financial Analyst at similar sized companies reported making $91,853.

Financial Analyst Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Financial Analyst at companies similar size to US Oncology reported making $98,729, while the average Native American Financial Analyst at similar sized companies reported making $60,000.

How Financial Analysts at US Oncology Rate Their Compensation

The majority of Financial Analysts at US Oncology believe they're compensated fairly. 50% of Financial Analysts at US Oncology say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at US Oncology

×
Rate your company